ADMA Biologics FY2026 Revenue expected to be more than $530.000M vs $535.360M Est

Benzinga · 1d ago
ADMA Biologics (NASDAQ:ADMA) FY2026 Revenue expected to be more than $530.000M vs $535.360M Est